View and download assets for Avellino media coverage.
Media contact: Eric Bernabei, CSMO, +1 (650) 396-3743, eric.bernabei@avellino.com
Fact Sheets
Fact Sheet 1 Avellino Company Background
Avellino is a precision medicine company focused on making a global impact in genetics to diagnose rare and challenging diseases, bringing new levels of efficiency and effectiveness to drug development, and making therapies more targeted to individual needs.
Fact Sheet 2 Avellino Technology Platforms
Avellino Labs leverages genetic big data and algorithms, collaborating with best-in-class partners to create genetic tests, gene-editing therapies, and genetic analytics for specialty diagnostics and personalized medicine.
Fact Sheet 3 AvellinoCoV2 Coronavirus Test
The COVID-19 outbreak has been fast and severe, first affecting the Avellino teams and facilities in China and South Korea.
Fact Sheet 4 Avellino Response Coronavirus Pandemic
Avellino is an early-stage, genetic-testing and personalized medicine company that did not have the resources to halt commercial sales and start producing the company’s novel AvellinoCoV2 test.
Videos
Facility B-roll
Lab Test/B-Roll
Interviews

John Hong
Chief People Officer and Interim General Counsel, Avellino Labs

Connie Chao-Shern, PhD, CLS
Chief Lab Officer, Avellino Labs

Eric Bernabei
Chief Sales and Marketing Officer, Avellino Labs
Audio Clips of Interview
- How AvellinoCoV2 Test is Different than Current Finger-prick and Test Strips
- Avellino Halted Production on Other Products to Increase Production of AvellinoCoV2 Test
- How the AvellinoCoV2 Test is Administered in 3 Easy Steps
- Why the AvellinoCoV2 Test is Different: Avellino’s Experience
- Why the AvellinoCoV2 Test Can Detect Coronavirus on Asymptomatic Patients
- Avellino Labs Overview
- Avellino’s Genetic Test Portfolio
- How It Was Determined That Avellino Could Create a Test to Detect COVID-19